imaging quality of most cardiac structures in practically all patients. [13] [14] [15] [16] In addition, the close proximity of the esophagus to the heart allows the use of higher transducer frequencies that increase image resolution. Moreover, transesophageal imaging permits the routine visualization of certain cardiac regions that often cannot be visualized from the precordial views, such as the left atrial appendage and the superior vena cava. 15, 16 The present study was undertaken to compare the diagnostic accuracy of transthoracic with that of transesophageal echocardiography for detecting cardiac and paracardiac masses.
Methods

Patients
For inclusion into this study, patients had to meet the following selection criteria: 1) presence of an intracardiac or paracardiac tumor or thrombus proven by surgery, autopsy, or other commonly accepted diagnostic procedure, such as computed tomography, magnetic resonance imaging, or angiography; 2) all patients had to be studied by precordial and by transesophageal echocardiography.
Magge et al Echocardiography in Cardiac Masses
71
According to these selection criteria, we included 93 consecutive patients (39 men, 54 women) who were between 20 and 82 years of age. Diagnoses of these patients are listed in Table 1 and were proven by surgery (n=67), autopsy (n=2), computed tomography (n = 29), magnetic resonance imaging (n =7), or angiography (n = 15).
Echocardiographic Examination
All patients were studied by conventional transthoracic echocardiography with 
Left and Right Atrial Myxomas
All 15 myxomas in the left (n = 13) and right atria (n =2) were correctly diagnosed by both the transthoracic and transesophageal approaches. In addition, the transesophageal echocardiogram revealed echolucent areas within the tumor in two patients, which were not detected on the precordial image ( Figure 1 ). All (Figure 1 ).
Thrombi
The detection rates for intracardiac and extracardiac thrombi are listed in Table 2 typical example of a left atrial thrombus that was not detected by the precordial examination is shown in Figure 2 . In two instances, the transesophageal echocardiogram identified a long thrombus straddling the interatrial septum through a patent foramen ovale (one instance) and a small atrial septal defect (one instance) ( Figure 3 ), which was subsequently confirmed by surgery; in these two instances, the precordial and subxiphoid views had suggested isolated masses within both atria.
Twelve patients had thrombi within the left atrial appendage proven by surgery (in three instances associated with a separate thrombus in the left atrial cavity); all thrombi were visible on the transesophageal echocardiogram ( Figure 4 ) but were not visible on the precordial echocardiogram. Three patients showed a thrombus in the superior vena Figure 5 ); in the remaining seven patients, right atrial tumors with or without involvement of the inferior vena cava were detected by both techniques. Whereas all six left-sided pericardiae or paracardiac tumors were correctly identified by both techniques, only nine of 14 right-sided pericardiac or paracardiac tumors were correctly identified by transthoracic echocardiography. The five tumors that were missed by the conventional approach but that were correctly identified by the transesophageal view ( Figure 6 ) were localized behind the sternum and lateral to the right ventricle (n=3), in the corner between the diaphragm and the heart (n=1), or could not be differentiated from a pericardial effusion by the precordial view (n = 1). Intracardiac tumors (invading from the inferior vena cava in six patients) also could be visualized by both techniques. In one patient, the tumor infiltration of the right ventricular wall could not be visualized by either technique. In another patient, the tumor penetration into the pulmonary artery could be visualized only by transesophageal echocardiography (Figure 7) . Also, in one patient with obstruction of the thoracic descending aorta by malignant histiocytoma, only the transesophageal technique demonstrated the tumor mass (Figure 8 ).
Discussion
The sensitivity of two-dimensional echocardiography for detecting intracardiac and paracardiac masses depends on the tumor size, acoustic properties, and location of the particular mass.
Cardiac Thrombi
Concerning the echocardiographic detection of left ventricular mural thrombi, a sensitivity of 90% or more has been reported.57,'7 Accordingly, all five thrombi localized in the apical region of the left ventricle were detected by precordial echocardiography in the present study. Transesophageal echocardiography is clearly inferior in detecting apical left ventricular thrombi compared with the conventional transthoracic approach. Thus, only one of the five corresponding thrombi could be unequivocally visualized from the esophagus. This is because the apical region of the heart is localized in the far field when imaged with high-frequency transducers from the esophagus; furthermore, an ideal image plane For the transthoracic echocardiographic detection of left atrial thrombi, a sensitivity between 38% and 61% has been reported.6,18-20 Although this sensitivity range is remarkably low, two-dimensional echocardiography is usually considered the method of choice for detecting left atrial thrombi. Previous studies show that small and flat atrial thrombi and thrombi obscured by the shadowing of prosthetic valves are usually undetected by precordial echocardiography. 6, 18, 20, 21 This was confirmed in the present study: all eight thrombi within the left atrial cavity undetected by precordial echocardiography were either small, flat mural masses or were found in a patient with mitral valve prosthesis. In these cases, the diagnostic potential of echocardiography can be markedly improved when the transesophageal approach is used. The same is true for the detection of thrombi limited to the left atrial appendage as reported previously.22-24 All 12 instances of thrombotic material within the left atrial appendage were undetected on the precordial echocardiogram but were clearly identified on the transesophageal echocardiogram. Whereas the atrial appendage can be visualized by precordial echocardiography only in rare instances when a modified parasternal short-axis view is applied,25 the cavity of the appendage becomes visible in practically all transesophageal echocardiograms.22 24 This fact is of particular importance when potential cardiac sources of thrombi have to be excluded in patients with arterial embolic events26 as well as before performing mitral valvuloplasty, in which the safety of the procedure is directly influenced by the presence or absence of thrombotic material within the left atrium and the appendage area.
Because transesophageal echocardiography allows a clear visualization of the atrial septum in the area of the fossa ovalis, a thrombus lodged in a patent foramen ovale or small atrial septal defect could be identified in two patients. Although this condition is a rare finding,27 it elucidates the potential risk of paradoxical embolism associated during any type of Valsalva maneuver in patients with a noncompetent atrial septum. 28 Right heart thrombi are a relatively rare finding,29 and in the present series, they could be identified by both echocardiographic techniques in all patients. This, however, is only true as long as thrombi are localized within the right atrium or ventricle. When thrombus involves the superior vena cava, the precordial approach usually fails to demonstrate its presence, whereas transesophageal echocardiography can reliably detect this mass as documented in our study. This is of clinical relevance in patients with pacemakers and long-standing intravenous lines who are under intensive care or who are receiving long-term chemotherapy. In addition, transesophageal echocardiography seems also to be a promising approach in the diagnosis of central pulmonary artery emboli.30
Cardiac Tumors
The diagnosis of atrial myxomas by transthoracic M-mode and, in particular, two-dimensional echocardiography is well established.',2Q31-36 In the present study, all right and left atrial myxomas were equally detected by both techniques. Transesophageal echocardiography, however, was slightly superior to precordial echocardiography in identifying the tumor attachment point and in identifying additional morphological details such as cysts. In selected patients, FIGURE 8 . Transesophageal echocardiogram (left) and corresponding diagram (right) demonstrating a mass (TU, malignant histiocytoma) localized beside the descending thoracic aorta (AO) that penetrated the lumen. E, esophagus.
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this superior ability to provide additional information on morphological details may be of clinical relevance with regard to the echocardiographic differentiation of myxomas from thrombi. 37, 38 Cardiac and paracardiac tumors (other than myxomas) could be echocardiographically evaluated in 32 patients in this study. Although in most patients both echocardiographic approaches led to a correct mass detection, the transesophageal technique was superior in identifying masses localized anterior to the heart or that had invaded the superior vena cava, pulmonary artery, or descending thoracic aorta. This is in good agreement with a recent report on 12 patients with paracardiac tumors, in which transthoracic echocardiography failed to identify masses in six patients. 39 Although the transesophageal technique seems to have high sensitivity for detecting intracardiac and paracardiac tumors, this technique cannot displace other diagnostic techniques such as computed tomography or magnetic resonance imaging.1' This is because echocardiographic information concerning tumor extent and tissue characterization is often limited. In addition, primary tumors of the heart are less frequent than metastatic masses, leading to the necessity of excluding tumor manifestations more distant from the heart. Transesophageal echocardiography, however, seems to be superior to the precordial technique as an initial screening procedure for cardiac tumors, at least for the particular tumor localizations mentioned above.
Limitations and Clinical Implications
This study has certain limitations as well as clinical implications. Patients with cardiac masses due to infective endocarditis were not included in this series because detection of these types of masses has been addressed previously.1440 In addition, the transesophageal echocardiographic results may have been influenced by the findings obtained by the preceding precordial approach; this bias, however, seems to be unavoidable because we believe that the transesophageal examination should not be performed without an earlier conventional study. Moreover, because only patients with proven cardiac masses were included in this study, conclusions are not possible concerning the specificity of the echocardiographic findings. Despite these limitations, our results clearly document that transesophageal echocardiography is the method of choice for detecting masses localized within the left atrial appendage and the superior vena cava. This is of particular clinical importance for patients with otherwise unexplained arterial embolism, for those scheduled for mitral valvuloplasty, and for those who have undergone short-or long-term instrumentation of the vena cava. The superior diagnostic potential of the transesophageal technique described for atrial appendage masses also holds true for small and flat thrombi within the atrial cavity. Cardiac tumors, in particular those lesions localized around the right heart, were more accessible when imaged from the esophagus; consequently, the transesophageal approach should be used in patients in whom a paracardiac mass is suspected but in whom precordial echocardiographic findings have been negative.
